Adiponectin multimer distribution in patients with familial combined hyperlipidemia

Biochemical and Biophysical Research Communications

Volumn 376, Issue 1, 2008, Pages 164-168

  Koenen, Tim B ^a   van Tits, Lambertus J H ^a   Holewijn, Suzanne ^a   Lemmers, Heidi L M ^a   den Heijer, Martin ^a   Stalenhoef, Anton F H ^a   de Graaf, Jacqueline ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adiponectin multimer distribution; Adiponectin multimers; Adiponectin sensitivity index; Cardiovascular disease; Cardiovascular risk; Familial combined hyperlipidemia

Indexed keywords

ADIPONECTIN; POLYMER;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FAMILIAL HYPERLIPEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEX DIFFERENCE;

ADIPOCYTES; ADIPONECTIN; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; MALE; MIDDLE AGED; SEX CHARACTERISTICS;

EID: 52349091296     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.08.111     Document Type: Article

References (40)

1. Funahashi T., Nakamura T., Shimomura I., Maeda K., Kuriyama H., Takahashi M., Arita Y., Kihara S., and Matsuzawa Y. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern. Med. 38 (1999) 202-206
2. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270 (1995) 26746-26749
3. Pajvani U.B., Du X., Combs T.P., Berg A.H., Rajala M.W., Schulthess T., Engel J., Brownlee M., and Scherer P.E. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J. Biol. Chem. 278 (2003) 9073-9085
4. Waki H., Yamauchi T., Kamon J., Ito Y., Uchida S., Kita S., Hara K., Hada Y., Vasseur F., Froguel P., Kimura S., Nagai R., and Kadowaki T. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J. Biol. Chem. 278 (2003) 40352-40363
5. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
6. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., Retzlaff B.M., Knopp R.H., Brunzell J.D., and Kahn S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
7. Kern P.A., Di Gregorio G.B., Lu T., Rassouli N., and Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52 (2003) 1779-1785
8. Matsubara M., Maruoka S., and Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J. Clin. Endocrinol. Metab. 87 (2002) 2764-2769
9. Yatagai T., Nagasaka S., Taniguchi A., Fukushima M., Nakamura T., Kuroe A., Nakai Y., and Ishibashi S. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52 (2003) 1274-1278
10. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., Arita Y., Okamoto Y., Shimomura I., Hiraoka H., Nakamura T., Funahashi T., and Matsuzawa Y. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 85-89
11. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
12. Maahs D.M., Ogden L.G., Kinney G.L., Wadwa P., Snell-Bergeon J.K., Dabelea D., Hokanson J.E., Ehrlich J., Eckel R.H., and Rewers M. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111 (2005) 747-753
13. Arita Y., Kihara S., Ouchi N., Maeda K., Kuriyama H., Okamoto Y., Kumada M., Hotta K., Nishida M., Takahashi M., Nakamura T., Shimomura I., Muraguchi M., Ohmoto Y., Funahashi T., and Matsuzawa Y. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105 (2002) 2893-2898
14. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., and Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
15. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., Ishigami M., Kuriyama H., Kishida K., Nishizawa H., Hotta K., Muraguchi M., Ohmoto Y., Yamashita S., Funahashi T., and Matsuzawa Y. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
16. Shimabukuro M., Higa N., Asahi T., Oshiro Y., Takasu N., Tagawa T., Ueda S., Shimomura I., Funahashi T., and Matsuzawa Y. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J. Clin. Endocrinol. Metab. 88 (2003) 3236-3240
17. van der Vleuten G.J., van Tits L.J., den Heijer M., Lemmers H., Stalenhoef A.F., and de Graaf J. Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile. J. Lipid Res. 46 (2005) 2398-2404
18. Ayyobi A.F., McGladdery S.H., McNeely M.J., Austin M.A., Motulsky A.G., and Brunzell J.D. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1289-1294
19. Soro A., Jauhiainen M., Ehnholm C., and Taskinen M.R. Determinants of low HDL levels in familial combined hyperlipidemia. J. Lipid Res. 44 (2003) 1536-1544
20. Vakkilainen J., Jauhiainen M., Ylitalo K., Nuotio I.O., Viikari J.S., Ehnholm C., and Taskinen M.R. LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins. J. Lipid Res. 43 (2002) 598-603
21. de Graaf J., Veerkamp M.J., and Stalenhoef A.F. Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids. J. R. Soc. Med. 95 Suppl. 42 (2002) 46-53
22. Austin M.A., McKnight B., Edwards K.L., Bradley C.M., McNeely M.J., Psaty B.M., Brunzell J.D., and Motulsky A.G. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation 101 (2000) 2777-2782
23. Hopkins P.N., Heiss G., Ellison R.C., Province M.A., Pankow J.S., Eckfeldt J.H., and Hunt S.C. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 108 (2003) 519-523
24. Ebinuma H., Miyazaki O., Yago H., Hara K., Yamauchi T., and Kadowaki T. A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin. Chim. Acta 372 (2006) 47-53
25. Basu R., Pajvani U.B., Rizza R.A., and Scherer P.E. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 56 (2007) 2174-2177
26. Bobbert T., Rochlitz H., Wegewitz U., Akpulat S., Mai K., Weickert M.O., Mohlig M., Pfeiffer A.F., and Spranger J. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 54 (2005) 2712-2719
27. Kobayashi H., Ouchi N., Kihara S., Walsh K., Kumada M., Abe Y., Funahashi T., and Matsuzawa Y. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 94 (2004) e27-e31
28. Pajvani U.B., Hawkins M., Combs T.P., Rajala M.W., Doebber T., Berger J.P., Wagner J.A., Wu M., Knopps A., Xiang A.H., Utzschneider K.M., Kahn S.E., Olefsky J.M., Buchanan T.A., and Scherer P.E. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279 (2004) 12152-12162
29. Veerkamp M.J., de Graaf J., Hendriks J.C., Demacker P.N., and Stalenhoef A.F. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study. Circulation 109 (2004) 2980-2985
30. Wetzels J.F., Kiemeney L.A., Swinkels D.W., Willems H.L., and den Heijer M. Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int. 72 (2007) 632-637
31. ter Avest E., Holewijn S., Stalenhoef A.F., and de Graaf J. Variation in non-invasive measurements of vascular function in healthy volunteers during daytime. Clin. Sci. (Lond.) 108 (2005) 425-431
32. Xu A., Chan K.W., Hoo R.L., Wang Y., Tan K.C., Zhang J., Chen B., Lam M.C., Tse C., Cooper G.J., and Lam K.S. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J. Biol. Chem. 280 (2005) 18073-18080
33. Miyatani Y., Yasui T., Uemura H., Yamada M., Matsuzaki T., Kuwahara A., Tsuchiya N., Yuzurihara M., Kase Y., and Irahara M. Associations of circulating adiponectin with estradiol and monocyte chemotactic protein-1 in postmenopausal women. Menopause 15 (2008) 536-541
34. Lara-Castro C., Luo N., Wallace P., Klein R.L., and Garvey W.T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55 (2006) 249-259
35. Liu Y., Retnakaran R., Hanley A., Tungtrongchitr R., Shaw C., and Sweeney G. Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. J. Clin. Endocrinol. Metab. 92 (2007) 4313-4318
36. Torigoe M., Matsui H., Ogawa Y., Murakami H., Murakami R., Cheng X.W., Numaguchi Y., Murohara T., and Okumura K. Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men. Clin. Endocrinol. (Oxf.) 67 (2007) 276-281
37. Nakashima R., Kamei N., Yamane K., Nakanishi S., Nakashima A., and Kohno N. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J. Clin. Endocrinol. Metab. 91 (2006) 3873-3877
38. Inoue T., Kotooka N., Morooka T., Komoda H., Uchida T., Aso Y., Inukai T., Okuno T., and Node K. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am. J. Cardiol. 100 (2007) 569-574
39. Hajer G.R., van der Graaf Y., Olijhoek J.K., Edlinger M., and Visseren F.L. Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease. Am. Heart J. 154 (2007) 750-757
40. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., and Hildebrandt P. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112 (2005) 1756-1762